Sign In
Get Clay Free →

Suggestions

    Gianluca Etienne

    Principal Scientist I at Novartis Institutes for BioMedical Research (NIBR)

    Gianluca Etienne is currently a Principal Scientist I at the Novartis Institutes for BioMedical Research (NIBR). He has a notable background in pharmaceutical research, particularly within the scope of drug discovery and development. Before assuming his current role, he participated in an Innovation Postdoctoral Fellowship at Novartis, where he engaged in both academic and industry-focused research initiatives.

    Professional Background

    • Current Position: Principal Scientist I at Novartis Institutes for BioMedical Research (NIBR).
    • Previous Role: Innovation Postdoctoral Fellow at Novartis, where he contributed to projects that balanced fundamental science with translational research aimed at impacting patient care directly.1

    Research Focus

    Etienne's work primarily involves evaluating and developing new methodologies for drug discovery. He has been involved in assessing biotech startups as potential collaborators, indicating a strong interest in integrating innovative approaches within pharmaceutical research.1 His insights suggest that industry postdocs like his own provide valuable experiences that bridge academic research with practical applications in drug development.

    Contributions

    Gianluca Etienne has also co-authored works focusing on the evolution of high-throughput screening systems and complex cellular assays, which are crucial for modern drug discovery processes.2 His contributions to the field highlight the importance of collaborative efforts between academic institutions and industry to foster advancements in biomedical research.

    Overall, Gianluca Etienne exemplifies the integration of scientific inquiry and practical application within the pharmaceutical industry, making significant strides in enhancing drug discovery methodologies at Novartis.

    Highlights

    Jun 25 · biospace.com
    Postdoc Programs at Pharmaceutical Companies: A Research Path ...
    Postdoc Programs at Pharmaceutical Companies: A Research Path ...
    [PDF] Building a Platform to Support Preclinical Drug Discovery
    Nov 13 · pubs.rsc.org
    Cross-talk between emulsion drops: how are hydrophilic reagents ...

    Related Questions

    What are Gianluca Etienne's main research interests?
    How did Gianluca Etienne transition from a postdoc to a principal scientist?
    What are the key differences between the innovation and discovery tracks at Novartis?
    How does Novartis support entrepreneurial and academic collaborations in its research programs?
    What challenges does Gianluca Etienne face due to proprietary restrictions in pharmaceutical research?
    Gianluca Etienne
    Gianluca Etienne, photo 1
    Gianluca Etienne, photo 2
    Add to my network

    Location

    Boston, Massachusetts, United States